Transcripts Q32 Bio Inc.

Equities

QTTB

US7469641051

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
29.04 ^USD	+3.64%		+17.00%	+165.35%

Apr. 11	Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target	MT
Apr. 03	Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Homology Medicines, Inc. - Special Call	23-07-27
Transcript : Homology Medicines, Inc. - Special Call	22-05-18
Transcript : Homology Medicines, Inc. - Special Call	22-01-28
Transcript : Homology Medicines, Inc. Presents at 30th Annual Credit Suisse Healthcare Conference, Nov-08-2021 10:30 AM	21-11-08
Transcript : Homology Medicines, Inc. Presents at BofA Napa Healthcare Conference, Jun-15-2021 12:30 PM	21-06-15
Transcript : Homology Medicines, Inc. - Special Call	21-05-13
Transcript : Homology Medicines, Inc. - Special Call	21-01-05
Transcript : Homology Medicines, Inc. - Special Call	20-11-06
Transcript : Homology Medicines, Inc. - Shareholder/Analyst Call	20-06-10
Transcript : Homology Medicines, Inc. Presents at BofA Securities 2020 Health Care Conference, May-12-2020 11:00 AM	20-05-12
Transcript : Homology Medicines, Inc. - Special Call	19-12-17
Transcript : Homology Medicines, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 through May-16-2019	19-05-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer